• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于动态决策的生存模型的时变判别精度评估教程。

A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.

机构信息

The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA (AB).

Department of Biostatistics, University of Washington, Seattle, WA (PJH).

出版信息

Med Decis Making. 2018 Nov;38(8):904-916. doi: 10.1177/0272989X18801312. Epub 2018 Oct 14.

DOI:10.1177/0272989X18801312
PMID:30319014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6584037/
Abstract

Many medical decisions involve the use of dynamic information collected on individual patients toward predicting likely transitions in their future health status. If accurate predictions are developed, then a prognostic model can identify patients at greatest risk for future adverse events and may be used clinically to define populations appropriate for targeted intervention. In practice, a prognostic model is often used to guide decisions at multiple time points over the course of disease, and classification performance (i.e., sensitivity and specificity) for distinguishing high-risk v. low-risk individuals may vary over time as an individual's disease status and prognostic information change. In this tutorial, we detail contemporary statistical methods that can characterize the time-varying accuracy of prognostic survival models when used for dynamic decision making. Although statistical methods for evaluating prognostic models with simple binary outcomes are well established, methods appropriate for survival outcomes are less well known and require time-dependent extensions of sensitivity and specificity to fully characterize longitudinal biomarkers or models. The methods we review are particularly important in that they allow for appropriate handling of censored outcomes commonly encountered with event time data. We highlight the importance of determining whether clinical interest is in predicting cumulative (or prevalent) cases over a fixed future time interval v. predicting incident cases over a range of follow-up times and whether patient information is static or updated over time. We discuss implementation of time-dependent receiver operating characteristic approaches using relevant R statistical software packages. The statistical summaries are illustrated using a liver prognostic model to guide transplantation in primary biliary cirrhosis.

摘要

许多医学决策都涉及使用针对个体患者收集的动态信息来预测其未来健康状况的可能转变。如果能够做出准确的预测,那么预后模型可以识别出未来发生不良事件风险最高的患者,并可用于临床定义适合靶向干预的人群。在实践中,预后模型通常用于指导疾病过程中多个时间点的决策,并且区分高危和低危个体的分类性能(即敏感性和特异性)可能会随着个体疾病状态和预后信息的变化而随时间变化。在本教程中,我们详细介绍了可用于描述用于动态决策的预后生存模型的时间变化准确性的现代统计方法。尽管用于评估具有简单二分类结果的预后模型的统计方法已经成熟,但适用于生存结果的方法却鲜为人知,并且需要对敏感性和特异性进行时间依赖性扩展,以充分描述纵向生物标志物或模型。我们回顾的方法特别重要,因为它们允许适当处理事件时间数据中常见的删失结果。我们强调确定临床关注点是预测固定未来时间间隔内的累积(或流行)病例,还是预测一系列随访时间内的新发病例,以及患者信息是静态的还是随时间更新的重要性。我们讨论了使用相关的 R 统计软件包实现时间依赖性接收者操作特征方法。使用原发性胆汁性肝硬化的肝脏预后模型来说明统计摘要,以指导肝移植。

相似文献

1
A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.用于动态决策的生存模型的时变判别精度评估教程。
Med Decis Making. 2018 Nov;38(8):904-916. doi: 10.1177/0272989X18801312. Epub 2018 Oct 14.
2
Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study.开发和验证扑热息痛诱导的急性肝衰竭的动态预后预测模型:一项队列研究。
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):217-225. doi: 10.1016/S2468-1253(16)30007-3. Epub 2016 Jul 13.
3
A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes.比较地标法和时间依赖型ROC方法以评估生存结局预后标志物的时变性能。
Diagn Progn Res. 2019 Jul 25;3:14. doi: 10.1186/s41512-019-0057-6. eCollection 2019.
4
Survival model predictive accuracy and ROC curves.生存模型预测准确性和ROC曲线。
Biometrics. 2005 Mar;61(1):92-105. doi: 10.1111/j.0006-341X.2005.030814.x.
5
Time-dependent ROC curve analysis in medical research: current methods and applications.医学研究中的时间依赖性ROC曲线分析:当前方法与应用
BMC Med Res Methodol. 2017 Apr 7;17(1):53. doi: 10.1186/s12874-017-0332-6.
6
Dynamic thresholds and a summary ROC curve: Assessing prognostic accuracy of longitudinal markers.动态阈值和总结 ROC 曲线:评估纵向标志物的预后准确性。
Stat Med. 2018 Aug 15;37(18):2700-2714. doi: 10.1002/sim.7675. Epub 2018 Apr 19.
7
Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate.基于连续协变量的时间依赖型ROC曲线的非参数估计。
Stat Med. 2016 Mar 30;35(7):1090-102. doi: 10.1002/sim.6769. Epub 2015 Oct 20.
8
Prognosis in primary biliary cirrhosis. A review.原发性胆汁性肝硬化的预后。综述。
Ital J Gastroenterol. 1991 May;23(4):222-6.
9
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.原发性胆汁性肝硬化和原发性硬化性胆管炎的肝移植:用自然史模型预测预后
Mayo Clin Proc. 1998 Jun;73(6):575-88. doi: 10.4065/73.6.575.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Dynamic nomogram for predicting long-term survival in patients with brain abscess.预测脑脓肿患者长期生存的动态列线图
Chin Neurosurg J. 2025 Aug 7;11(1):15. doi: 10.1186/s41016-025-00402-w.
2
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).利用动态生物标志物对冒烟型多发性骨髓瘤进行强化风险分层:一项纳入2270名参与者的多国多中心研究(PANGEA 2.0)。
Res Sq. 2025 Jun 3:rs.3.rs-6696313. doi: 10.21203/rs.3.rs-6696313/v1.
3
NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis.

本文引用的文献

1
A risk-based measure of time-varying prognostic discrimination for survival models.生存模型中基于风险的时变预后判别度量。
Biometrics. 2017 Sep;73(3):725-734. doi: 10.1111/biom.12628. Epub 2016 Nov 28.
2
Predicting outcome in primary biliary cirrhosis.预测原发性胆汁性肝硬化的预后。
Ann Hepatol. 2014 Jul-Aug;13(4):316-26.
3
Boosting the concordance index for survival data--a unified framework to derive and evaluate biomarker combinations.提高生存数据的一致性指数——一种用于推导和评估生物标志物组合的统一框架。
NLRP3炎症小体相关基因作为银屑病中新出现的生物标志物和治疗靶点
Inflammation. 2025 Mar 3. doi: 10.1007/s10753-025-02271-y.
4
Association of nonstandardized model for end-stage liver disease score exceptions with waitlist mortality in adult liver transplant candidates.成人肝移植候选者中终末期肝病评分异常的非标准化模型与等待名单死亡率的关联。
Am J Transplant. 2025 Feb;25(2):385-395. doi: 10.1016/j.ajt.2024.09.028. Epub 2024 Sep 26.
5
Improving pressure injury risk assessment using real-world data from skilled nursing facilities: A cohort study.利用熟练护理设施的真实世界数据改善压力性损伤风险评估:一项队列研究。
Int Wound J. 2024 Jul;21(7):e70000. doi: 10.1111/iwj.70000.
6
Prognoses Associated With Palliative Performance Scale Scores in Modern Palliative Care Practice.在现代姑息治疗实践中,与姑息治疗表现量表评分相关的预后。
JAMA Netw Open. 2024 Jul 1;7(7):e2420472. doi: 10.1001/jamanetworkopen.2024.20472.
7
Mortality prediction and influencing factors for intensive care unit patients with acute tubular necrosis: random survival forest and cox regression analysis.急性肾小管坏死重症监护病房患者的死亡率预测及影响因素:随机生存森林与Cox回归分析
Front Pharmacol. 2024 May 23;15:1361923. doi: 10.3389/fphar.2024.1361923. eCollection 2024.
8
Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.头颈部癌放射性骨坏死分类系统的制定与标准化:风险模型的应用。
J Clin Oncol. 2024 Jun 1;42(16):1922-1933. doi: 10.1200/JCO.23.01951. Epub 2024 May 1.
9
Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates.成人心脏移植候选者死亡而无需移植的风险评分的制定和验证。
JAMA. 2024 Feb 13;331(6):500-509. doi: 10.1001/jama.2023.27029.
10
Using Machine Learning to Leverage Biomarker Change and Predict Colorectal Cancer Recurrence.使用机器学习利用生物标志物变化预测结直肠癌复发。
JCO Clin Cancer Inform. 2023 Sep;7:e2300066. doi: 10.1200/CCI.23.00066.
PLoS One. 2014 Jan 6;9(1):e84483. doi: 10.1371/journal.pone.0084483. eCollection 2014.
4
Development and evaluation of multi-marker risk scores for clinical prognosis.用于临床预后的多标志物风险评分的开发与评估
Stat Methods Med Res. 2016 Feb;25(1):255-71. doi: 10.1177/0962280212451881. Epub 2012 Jul 5.
5
Non-parametric estimation of a time-dependent predictive accuracy curve.基于时间的预测精度曲线的非参数估计。
Biostatistics. 2013 Jan;14(1):42-59. doi: 10.1093/biostatistics/kxs021. Epub 2012 Jun 25.
6
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.将净重新分类改进计算扩展到测量新生物标志物的有用性。
Stat Med. 2011 Jan 15;30(1):11-21. doi: 10.1002/sim.4085. Epub 2010 Nov 5.
7
Time-dependent predictive accuracy in the presence of competing risks.存在竞争风险时的时间依赖性预测准确性。
Biometrics. 2010 Dec;66(4):999-1011. doi: 10.1111/j.1541-0420.2009.01375.x.
8
Assessing the performance of prediction models: a framework for traditional and novel measures.评估预测模型的性能:传统和新型指标的框架。
Epidemiology. 2010 Jan;21(1):128-38. doi: 10.1097/EDE.0b013e3181c30fb2.
9
Survival analysis with high-dimensional covariates.高维协变量的生存分析。
Stat Methods Med Res. 2010 Feb;19(1):29-51. doi: 10.1177/0962280209105024. Epub 2009 Aug 4.
10
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.心血管风险新标志物评估标准:美国心脏协会的科学声明
Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13.